308 related articles for article (PubMed ID: 8489494)
1. The bioactive phospholipid lysophosphatidic acid is released from activated platelets.
Eichholtz T; Jalink K; Fahrenfort I; Moolenaar WH
Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):677-80. PubMed ID: 8489494
[TBL] [Abstract][Full Text] [Related]
2. Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood.
Sano T; Baker D; Virag T; Wada A; Yatomi Y; Kobayashi T; Igarashi Y; Tigyi G
J Biol Chem; 2002 Jun; 277(24):21197-206. PubMed ID: 11929870
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
[TBL] [Abstract][Full Text] [Related]
4. Serum lysophosphatidic acid is produced through diverse phospholipase pathways.
Aoki J; Taira A; Takanezawa Y; Kishi Y; Hama K; Kishimoto T; Mizuno K; Saku K; Taguchi R; Arai H
J Biol Chem; 2002 Dec; 277(50):48737-44. PubMed ID: 12354767
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells.
Yatomi Y; Ohmori T; Rile G; Kazama F; Okamoto H; Sano T; Satoh K; Kume S; Tigyi G; Igarashi Y; Ozaki Y
Blood; 2000 Nov; 96(10):3431-8. PubMed ID: 11071638
[TBL] [Abstract][Full Text] [Related]
6. Synergistic activation of human platelets by lysophosphatidic acid and adrenaline.
Nilsson U; Svensson SP; Grenegård M
Haematologica; 2002 Jul; 87(7):730-9; discussion 739. PubMed ID: 12091124
[TBL] [Abstract][Full Text] [Related]
7. Membrane sidedness of biosynthetic pathways involved in the production of lysophosphatidic acid.
le Balle F; Simon MF; Meijer S; Fourcade O; Chap H
Adv Enzyme Regul; 1999; 39():275-84. PubMed ID: 10470378
[TBL] [Abstract][Full Text] [Related]
8. [Lysophosphatidic acid: a "bioactive" phospholipid].
Saulnier-Blache JS
Med Sci (Paris); 2004; 20(8-9):799-803. PubMed ID: 15361348
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid is the unique platelet-activating substance in human malignant ascites.
Sandmann G; Siess W; Essler M
Eur J Med Res; 2003 Sep; 8(9):397-404. PubMed ID: 14555295
[TBL] [Abstract][Full Text] [Related]
10. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: similarity to thrombin action.
Jalink K; Eichholtz T; Postma FR; van Corven EJ; Moolenaar WH
Cell Growth Differ; 1993 Apr; 4(4):247-55. PubMed ID: 7684247
[TBL] [Abstract][Full Text] [Related]
12. Selective non-lipid modulator of LPA5 activity in human platelets.
Kozian DH; Evers A; Florian P; Wonerow P; Joho S; Nazare M
Bioorg Med Chem Lett; 2012 Aug; 22(16):5239-43. PubMed ID: 22801643
[TBL] [Abstract][Full Text] [Related]
13. Lipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activity.
Smyth SS; Sciorra VA; Sigal YJ; Pamuklar Z; Wang Z; Xu Y; Prestwich GD; Morris AJ
J Biol Chem; 2003 Oct; 278(44):43214-23. PubMed ID: 12909631
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome.
Kurano M; Suzuki A; Inoue A; Tokuhara Y; Kano K; Matsumoto H; Igarashi K; Ohkawa R; Nakamura K; Dohi T; Miyauchi K; Daida H; Tsukamoto K; Ikeda H; Aoki J; Yatomi Y
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):463-70. PubMed ID: 25425621
[TBL] [Abstract][Full Text] [Related]
15. Patients with risk factors have higher plasma levels of lysophosphatidic acid: a promising surrogate marker for blood platelet activation.
Yao CS; Yan SG; Gao LS; Sun ZR; Liu F; Jiang B; Wang HB; Wu QZ
Blood Coagul Fibrinolysis; 2014 Jun; 25(4):322-5. PubMed ID: 24346355
[TBL] [Abstract][Full Text] [Related]
16. Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway.
Pamuklar Z; Lee JS; Cheng HY; Panchatcharam M; Steinhubl S; Morris AJ; Charnigo R; Smyth SS
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):555-61. PubMed ID: 18202325
[TBL] [Abstract][Full Text] [Related]
17. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist.
McIntyre TM; Pontsler AV; Silva AR; St Hilaire A; Xu Y; Hinshaw JC; Zimmerman GA; Hama K; Aoki J; Arai H; Prestwich GD
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):131-6. PubMed ID: 12502787
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid.
Yatomi Y; Yamamura S; Ruan F; Igarashi Y
J Biol Chem; 1997 Feb; 272(8):5291-7. PubMed ID: 9030602
[TBL] [Abstract][Full Text] [Related]
19. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin.
Gerrard JM; Robinson P
Biochim Biophys Acta; 1989 Feb; 1001(3):282-5. PubMed ID: 2917152
[TBL] [Abstract][Full Text] [Related]
20. Thrombogenic and atherogenic activities of lysophosphatidic acid.
Siess W; Tigyi G
J Cell Biochem; 2004 Aug; 92(6):1086-94. PubMed ID: 15258894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
